(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. Sox9 deletion in the oligodendrocyte lineage. (A) Schematic
representation of Sox9 and Sox10 alleles and the
Sox10::Cre transgene used in this study. Boxes represent exons with
translated parts being filled or expression cassettes for neomycin resistance
(neo), β-galactosidase (lacZ) and Cre recombinase (Cre). Ellipses
indicate positions of loxP sites, arrowheads those of genotyping primers a-i.
(B-M) Sox9 immunoreactivity (red) was detected at 12.5 dpc (B-G) and
15.5 dpc (H-M) alone (B,E,H,K) or together with Olig2 (C,F,I,L) or Sox10
(D,G,J,M) immunoreactivity (green) in transverse spinal cord sections from the
forelimb region of wild-type (B,C,D,H,I,J) or Sox9loxP/loxP,
Sox10::Cre
(Sox9
/
)
(E,F,G,K,L,M) embryos. The region from which I,J,L,M were taken is boxed in H
and K.